The Newburger-Bellinger Cardiac Neurodevelopmental Award was established in 2013 by the Cardiac Neurodevelopmental Outcome Collaborative to honor Jane Newburger and David Bellinger, pioneers in research designed to understand and improve neurodevelopmental outcomes for children with heart disease. The award is presented annually at the Scientific Sessions of the Cardiac Neurodevelopmental Outcome Collaborative.
Newburger-Bellinger Cardiac Neurodevelopmental Award
NOMINATIONS ACCEPTED between January 15 and March 17, 2019.
Criteria for nomination: A cardiologist, surgeon, anesthesiologist, neurologist, developmental pediatrician, geneticist, psychologist, nurse, PhD researcher, or other neurodevelopmental professional who has made significant contributions to clinical care, research knowledge, teaching or community advocacy leading to improvements in the neurodevelopmental outcomes of children with heart disease. Please forward this page to other colleagues who may be interested. Membership in CNOC is not a factor.
Submit a letter of support that details the nominee’s significant contribution to Kelly Wolfe, CNOC Secretary. All letters of nomination will be reviewed by the Steering Committee, and all nominees notified by April 1. The selected award recipient will deliver a keynote address at the 8th Annual Scientific Sessions of the Cardiac Neurodevelopmental Outcome Collaborative in Toronto, Ontario, October 11-13, 2019.
2018 Recipient – Bradley S. Marino MD MPP MSCE
Co-Director of Research and Academic Affairs within the Heart Center at the Ann & Robert H. Lurie Children’s Hospital of Chicago
For the last 20 years, Dr. Bradley Marino’s research has focused on measuring and improving long-term outcomes in neonates, infants, children, and adolescents with complex congenital heart disease (CHD). Dr. Marino is an international expert on cardiac intensive care, resuscitation, and the impact of neurodevelopmental, psychosocial, and physical morbidities on quality of life (QOL), functional status, and behavioral/emotional outcomes in the high-risk complex CHD population. He has a special interest in long-term outcomes in single-ventricle survivors.
Dr. Marino has led and participated in multiple NIH and other foundation-funded studies assessing modifiable predictors of long-term outcomes in the high-risk complex CHD population. Dr. Marino has advanced training in public policy and clinical epidemiology. As Co-Director of Research and Academic Affairs within the Heart Center at the Ann & Robert H. Lurie Children’s Hospital of Chicago, he has lead research and academic affairs, pursued work as a principal investigator in cardiovascular research and mentored fellows and faculty in the Heart Center.
Dr. Marino’s ardent goal is to create academic and research infrastructure to assist fellows and faculty in the Heart Center to have successful academic careers and improve patient outcomes and family experience. His major contributions to science include QOL assessment and neurodevelopmental outcomes in pediatric and CHD survivors, single ventricle CHD outcomes, and resuscitation science.
Read a summary of Dr. Marino’s acceptance presentation, ‘Neurodevelopmental Perspectives: The Scientist, The Physician, The National Advocate, The Humble Traveler’.